78756-36-2

Basic information

• Product Name: 7-BROMO-4-METHYL-3,4-DIHYDRO-1H-BENZO[E][1,4]DIAZEPINE-2,5-DIONE
• Synonyms: 7-BROMO-4-METHYL-3,4-DIHYDRO-1H-BENZO[E][1,4]DIAZEPINE-2,5-DIONE;7-BroMo-3,4-Dihydro-4-Methyl-1H-1,4-Benzodiazepine-2,5-Dione
• CAS NO: 78756-36-2
• Molecular Formula: C10H9BrN2O2
• Molecular Weight: 269.09
• Mol File: 78756-36-2.mol
• Article Data: 12

Chemical Properties

• Boiling Point: 480.7°C at 760 mmHg
• Flash Point: 244.5°C
• Appearance: /
• Density: 1.58g/cm³
• Vapor Pressure: 2.12E-09mmHg at 25°C
• Refractive Index: 1.596
• CAS DataBase Reference: 7-BROMO-4-METHYL-3,4-DIHYDRO-1H-BENZO[E][1,4]DIAZEPINE-2,5-DIONE(CAS DataBase Reference)
• NIST Chemistry Reference: 7-BROMO-4-METHYL-3,4-DIHYDRO-1H-BENZO[E][1,4]DIAZEPINE-2,5-DIONE(78756-36-2)
• EPA Substance Registry System: 7-BROMO-4-METHYL-3,4-DIHYDRO-1H-BENZO[E][1,4]DIAZEPINE-2,5-DIONE(78756-36-2)

Safety Data

• Hazardous Substances Data: 78756-36-2(Hazardous Substances Data)

Usage

General Description

7-Bromo-4-methyl-3,4-dihydro-1H-benzo[e][1,4]diazepine-2,5-dione is an organic compound that belongs to the family of benzodiazepines. It is a yellow solid with a molecular formula C10H9BrN2O2. This chemical has potential uses in pharmaceutical research and drug development due to its structural similarity to other benzodiazepines, which are known for their psychoactive and anxiolytic properties. Additionally, it may have applications in the field of medicinal chemistry and neuroscience, as benzodiazepines have been widely studied for their effects on the central nervous system and their potential as therapeutic agents for various neurological and psychiatric disorders.

InChI:InChI=1/C10H9BrN2O2/c1-13-5-9(14)12-8-3-2-6(11)4-7(8)10(13)15/h2-4H,5H2,1H3,(H,12,14)

Upstream product

• 3415-35-8 4-methyl-3H-1,4-benzodiazepine-2,5-(1H,4H)-dione 
• 107-97-1 sarcosine 
• 67-68-5 dimethyl sulfoxide 
• 4692-98-2 5-bromoisatoic anhydride 
• 118-48-9 isatoic anhydride 

Downstream Products

• 78756-37-3 ethyl 8-bromo-5-methyl-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate 
• 646066-59-3 XLi-093 
• 1286792-27-5 C₂F₃O₂^(1-)*C₂₁H₁₉IN₃O₃⁽¹⁺⁾ 

Relevant articles and documents

The synthesis and anti-inflammatory evaluation of 1,2,3-triazole linked isoflavone benzodiazepine hybrids

Copper catalyzed azide-alkyne cycloaddition was used for the first time to access a small series of eight novel 1,2,3-triazole linked isoflavone benzodiazepine hybrids. As part of this work, a previously unreported alkyne substituted pyrrolo[1,4]benzodiaz

Enhanced copper-mediated 18F-fluorination of aryl boronic esters provides eight radiotracers for PET applications

[18F]FMTEB, [18F]FPEB, [18F]flumazenil, [18F]DAA1106, [18F]MFBG, [18F]FDOPA, [18F]FMT and [18F]FDA are prepared from the corresponding arylboronic esters and [18

PREPARATION METHOD OF FLUMAZENIL LABELED WITH FLUORINE-18 USING DIARYL IODONIUM SALT PRECURSOR

Disclosed is the synthesis of [18F]flumazenil that is useful in imaging epileptic lesions by PET (positron emission tomography). A method for preparing [18F]flumazenil by reacting a diaryliodonium salt precursor with the positron-emi